Collectively, given the significant contribution of Fetuin-A in inflammatory signaling and metabolic processes, it might represent a potential target for the treatment of metabolic diseases, including insulin resistance and type 2 diabetes. This evidence concerns the gene AHSG and Insulin resistance.